18F-PF-05270430

N/A

Report date: 2025/11/24 17:27:43
NME

Base Information

Drug Name18F-PF-05270430
Drug Alias NameFluorine-PF-0430PF-05270430-[18F]Fluorine-18-PF-0527043018F-PF-05270430
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionPhosphodiesterase 2A inhibitorsPositron-emission tomography enhancers
TargetsPhosphodiesterase 2A
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A